483
SHIBUYA CORPORATIONFDA 483 - SHIBUYA CORPORATION - February 01, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Shibuya Corporation, a device manufacturer in Kanazawa, Japan, revealed significant issues with their quality system. The firm failed to adequately establish procedures for Corrective and Preventive Action (CAPA) and did not properly control products that did not conform to specifications. These deficiencies indicate a need for improved quality management practices to ensure product safety and effectiveness.
Open in Dashboard
ID · 1b992c12-0833-4850-a340-d6aedbab1d04